Fibrobody-drug conjugates:
We unlock the potential of powerful molecules by building them into smart, targeted medicines.

LinXis is the world's first and only fibrobody-drug conjugate company

We are the first to use targeted delivery methods to combat fibrosis - a condition that afflicts millions of people worldwide. Our approach towards fibrosis is not only about extending and saving lives, but also about improving quality of life for those suffering fibrotic disease. Many fibrosis patients are young; our aim is to give them the chance to lead a healthy, happy life.

Linking medicines to in-house developed Fibrobodies™

We can selectively deliver proven medicines to fibrotic tissue, in order to selectively de-activate fibrosis-mediating cells.

Our solution harnesses the power of existing medicines by coupling them to in-house developed Fibrobodies™ using our own ‘plug and play’ conjugation technology.

Our Fibrobodies™ and conjugation technology are protected by several patent applications.

Image: graphical rendering of the actual spatial structure of a Fibrobody

We are tackling a growing health concern

Research points to long-term growth in a multitude of fibrotic illnesses.

Long term growth

The potential to diversify and maximize impact

We pursue sub-approaches for multiple fibrotic diseases by targeting Fibrobodies to liver, lung, kidney or gut.

Liver fibrosis

Kidney fibrosis

Lung fibrosis

Fibrosis of the gut

We are experienced pioneers, ready to take the next step

With an experienced, close-knit scientific team, we are ready to take our solution to the next level. We hold all required knowledge and expertise under one roof - LinXis’ specialists self-manage the entire pharmaceutical development cycle – from Fibrobody-drug conjugate design to preclinical- and clinical development.

Portret

Bart Nijmeijer PhD

Chief Executive Officer
Portret

Prof. Guus van Dongen

Chief Scientific Officer
Portret

Samuel Oudkerk

Chief Business & Financial Officer

Contact us

Join our mission. Join us.

LinXis is always open to possibilities that could support our company and our pipeline. Do not hesitate to reach out to us.

LinXis B.V.

Cronenburg 75
1081 GM  Amsterdam
The Netherlands

Join our mission. Join us.

LinXis is always open to possibilities that could support our company and our pipeline. Do not hesitate to reach out to us.

For inquiries please mail us.

mail us
Amsterdam UMC - Imaging Center

LinXis and the Amsterdam UMC Imaging Center

Our scientific and technical staff are located in the Amsterdam Imaging Center: an award-winning facility in which all disciplines required for image-guided drug development - from organic tracer chemistry to clinical diagnostics - are unified under one single roof.